Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($) $ in Thousands	Total	Cumulative effect of adoption of ASU 2020-06	Common Stock	Additional Paid-in Capital	Additional Paid-in Capital Cumulative effect of adoption of ASU 2020-06	Accumulated Deficit	Accumulated Deficit Cumulative effect of adoption of ASU 2020-06	Accumulated Other Comprehensive Income
Beginning balance (in shares) at Dec. 31, 2021			12,917,027
Beginning balance at Dec. 31, 2021	$ 671,266	$ (12,050)	$ 129	$ 982,746	$ (20,726)	$ (313,495)	$ 8,676	$ 1,886
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	53,073					53,073
Dividends	(27,112)					(27,112)
Issuance of shares due to vesting of equity awards (in shares)			60,890
Issuance of shares due to vesting of equity awards	0		$ 1	(1)
Issuance of shares upon exercise of stock options (in shares)			8,077
Issuance of shares upon exercise of stock options	85			85
Effect of cash flow hedges	8,681							8,681
Fees for equity offerings	201			201
Cash used to settle net share equity awards	(1,862)			(1,862)
Stock-based compensation	1,487			1,487
Ending balance (in shares) at Mar. 31, 2022			12,985,994
Ending balance at Mar. 31, 2022	693,769		$ 130	961,930		(278,858)		10,567
Beginning balance (in shares) at Dec. 31, 2022			13,003,702
Beginning balance at Dec. 31, 2022	819,181		$ 130	966,058		(163,556)		16,549
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	3,202					3,202
Dividends	(8,019)					(8,019)
Issuance of shares due to vesting of equity awards (in shares)			61,358
Issuance of shares due to vesting of equity awards	0		$ 1	(1)
Effect of cash flow hedges	(2,859)							(2,859)
Cash used to settle net share equity awards	(1,651)			(1,651)
Stock-based compensation	1,855			1,855
Ending balance (in shares) at Mar. 31, 2023			13,065,060
Ending balance at Mar. 31, 2023	$ 811,709		$ 131	$ 966,261		$ (168,373)		$ 13,690